News1 week ago
Versanis Bio Announces Completion of Enrollment of the BELIEVE Phase 2b Study in Patients with Obesity
The global Phase 2b study assessing bimagrumab as a single agent and in combination with semaglutide in patients with obesity aims to evaluate its potential to...
